Search clinical trials for: Levonorgestrel IUS

Total 510 results

Hua Li

Recruiting

Medroxyprogesterone Acetate vs LNG-IUS in Early-stage Endometrioid Carcinoma and Atypical Hyperplasia Patients

Fertility Sparing

China
KK Women's and Children's Hospital

Recruiting

A Pilot Study on Fertility Conservative Treatment of Atypical Endometrial Hyperplasia in Singapore

Endometrial Hyperplasia | Fertility Issues | Treatment Side Effects | Disease Regression

Singapore
Makerere University
Karolinska Institutet

Not yet recruiting

Ideal Timing of Intrauterine Contraception Insertion After Medical Management of First Trimester Incomplete Abortion (PAIC)

Misoprostol | Incomplete Abortion | Intrauterine Contraception

Uganda
Xiaojun Chen

Recruiting

Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia

Atypical Endometrial Hyperplasia | Fertility Issues | Overweight and Obesity

China
FHI 360
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Recruiting

Levonorgestrel Intrauterine System Effects on Hemoglobin and Serum Ferritin Among Anemic Women in Kenya (LISA)

Anemia

Kenya
Fudan University

Recruiting

Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia

Obesity | Atypical Endometrial Hyperplasia | Fertility Issues

China
Wael Elbanna Clinic
National Research Centre, Egypt

Recruiting

Ambispective Study to Assess the Effect of Pretreatment With a Levonorgestrel-Releasing Intrauterine System Versus Oral Progestin

Adenomyosis | IVF

Egypt
United States Naval Medical Center, Portsmouth

Terminated

A Multicenter Analysis of Levonorgestrel-Intrauterine System (LNG-IUS) Use in the Postpartum Period

Contraception | Postpartum Period

United States
United States Naval Medical Center, Portsmouth

Completed

Levonorgestrel-Intrauterine System (LNG-IUS) Insertion in the Postpartum Period

Contraception

United States
Planned Parenthood of the St. Louis Region and...
University of Colorado, Denver; University of Rochester; Planned Parenthood Federation... and other collaborators

Completed

Levonorgestrel Intrauterine System For Emergency Contraception (LIFE)

Pregnancy, Unplanned | Pregnancy; Accident

United States
Center for Epidemiology and Health Research, Germany
Bayer

Active, not recruiting

European Active Surveillance Study of LCS12 (EURAS_LCS12)

Contraception

Germany
Bayer

Completed

A Study Run at Multiple Study Sites to Test Whether the SAMANTA Questionnaire That is Used to Diagnose Heavy Menstrual Bleeding (HMB), Can Also be Used to Assess Changes of Severity of HMB in Women With HMB Who Are Treated During 12 Months With a Chronic Hormonal Treatment (SAMIRA)

Menorrhagia

Spain
Eastern Virginia Medical School
United States Agency for International Development (USAID); CONRAD; Kenya Medical...

Completed

Impact of Contraceptives on Cervico-Vaginal Mucosa (UMPALA)

Contraceptive; Complications, Intrauterine | Mucosal Inflammation

United States, Kenya
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Withdrawn

Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in the Management of Atypical Endometrial Hyperplasia

Endometrial Hyperplasia

United States
Bayer

Completed

The Aim of This Study is to Estimate the Discontinuation Rate of Low-dose Levonorgestrel-releasing Intrauterine System Due to Self-reported Unacceptable Menstrual Bleeding Pattern in Spanish Women Who Are Using it for the First Time How Intrauterine System for Long Acting Contraception (CORA)

Hormonal Intrauterine Contraception

Spain
University of Chicago

Terminated

Postplacental Insertion of Levonorgestrel-releasing Intrauterine System (LNG-IUS) After Cesarean vs. Interval Insertion

Healthy

United States
University of Chicago
University of Illinois at Chicago

Completed

Maintaining Intrauterine Devices (IUDs) in Teens (MINT): A Randomization Trial (MINT)

Contraception

United States
Zagazig University

Completed

LVN- IUS Versus Oral Megesterol Acetate in Treatment of Atypical Endometrial Hyperplasia

Atypical Endometrial Hyperplasia

Egypt
Bayer

Completed

Mirena Extension Trial (MET)

Contraception

United States
Shannon K. Laughlin-Tommaso
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids

Uterine Fibroids | Menorrhagia | Heavy Menstrual Bleeding

United States
Bayer

Completed

KYleena Satisfaction Study / Observational Study on User Satisfaction With the Levonorgestrel Intrauterine Delivery System Kyleena (LNG-IUS 12) in New Contraceptive Users and After Switching From Another Contraceptive Method (KYSS)

Contraception

Canada, Spain, Germany, Sweden, Mexico, Belgium, United States, Norway
University of Cagliari

Unknown

Comparison of Estrogen-progestin Therapy in Continuous Regimen Versus Combination Estrogen-progestin Therapy in Continuous Regimen Plus Levonorgestrel-releasing Intrauterine System (LNG-IUS)

Adenomyosis | Chronic Pelvic Pain
Bayer

Completed

Prospective, Non-interventional, Multi-center Safety Study of Mirena for Heavy Menstrual Bleeding and Dysmenorrhea (J-MIRAI)

Menorrhagia, Dysmenorrhea

Japan
Fudan University

Completed

Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial Cancer

Endometrial Neoplasm Malignant Stage I

China
Fudan University
Zhejiang Cancer Hospital; Shanghai 6th People's Hospital; Shanghai Changning...

Completed

Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia

Atypical Endometrial Hyperplasia

China
University of Colorado, Denver
Society of Family Planning

Completed

Comparison of the Levonorgestrel IUD and the Copper IUD Placed in the Immediate Postplacental Period: A Prospective Cohort Study

Contraception

United States
Oregon Health and Science University

Completed

Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS)

Metrorrhagia | Menorrhagia | Medicated Intrauterine Devices

United States
Oregon Health and Science University
Society of Family Planning

Terminated

Early Postpartum Intrauterine Device (IUD) Placement

Contraception

United States
FHI 360
Oregon Health and Science University; Asociación Dominicana Pro Bienestar de...

Completed

Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods

Contraception

United States, Dominican Republic
Omar Mamdouh Shaaban

Completed

LNG-IUS for Treatment of Dysmenorrhea (LNGIUSAD)

Adenomyosis
University of North Carolina, Chapel Hill
Society of Family Planning

Completed

LNG-IUS at 2 Weeks Postpartum (LNG-IUS)

Contraception | Malposition of Intrauterine Contraceptive Device

United States
University of North Carolina, Chapel Hill

Completed

A Pilot Study of Early Postpartum Intrauterine Contraception (ImmPPIUD)

Unplanned Pregnancy

United States
King Chulalongkorn Memorial Hospital

Completed

Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients

Endometriosis

Thailand
Bayer
University of Utah

Completed

Duration of Use of Highly Effective Reversible Contraception

Pregnancy

United States
Bayer

Completed

Levonorgestrel Contraceptive Intrauterine Systems (LCS) Pearl Index Study

Contraception

Sweden, United States, France, Hungary, Netherlands, Chile, Canada, Finland, Mexico, Argentina, Norway
Chulalongkorn University

Completed

Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients

Clinically Diagnosed Endometriotic Patient Was Defined as a Woman Who Has Pelvic Pain and at Least One Evidence of PV or TVS
Karolinska Institutet

Completed

Pretreatment With Mifepristone Prior to Mirena Insertion (MiMi)

Women in Need of Long Acting Reversibel Cntraception With the Intrauterine Levonorgestrel Releasing System, Mirena

Sweden
Columbia University
Bayer

Completed

Women With Epilepsy: a Pilot Study of PK and PD Anti-epileptic Drug Effects in Levonorgestrel Intrauterine System Users (WESAIL)

Epilepsy | Contraception

United States
Bayer

Completed

Bleeding Pattern Difference Between Levonorgestrel Intrauterine System (LNG-IUS) and Copper Intrauterine Devices (IUDs) Immediately Inserted After Abortion (POST)

Contraception

China
Bayer

Completed

Dose-finding Study for the Ultralow-dose Levonorgestrel Intrauterine Contraceptive System (LCS)

Contraception

Sweden, Finland, Hungary, Norway, United Kingdom
Bayer

Completed

FR01 and FR20 IUS (Intrauterine System) Wearing Study

Contraception

Sweden, Netherlands, Finland
Bayer

Completed

Mirena in Idiopathic Menorrhagia

Idiopathic Menorrhagia

Croatia, Saudi Arabia, Bulgaria, Jordan, Romania, Russian Federation, Turkey, United Arab Emirates, Kuwait, India, Pakistan, Serbia, Sri Lanka
University of Sao Paulo
Conselho Nacional de Desenvolvimento Científico e Tecnológico

Completed

Effect of Intracervical on the Pain Associated With the Insertion of the LNG-IUS

Pain

Brazil
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo; Conselho Nacional de...

Completed

Levonorgestrel-releasing Intrauterine System in Patients With Endometriosis (SIU-LNG)

Endometriosis

Brazil
Bayer

Completed

Management of Initial Bleeding/Spotting Associated With the Levonorgestrel-releasing Intrauterine System (MIRENA)

Uterine Hemorrhage

Ireland, Denmark, Norway
Bayer

Completed

GA Levonorgestrel Intrauterine Contraceptive System (LCS) Phase III Study China

Contraception

China, Korea, Republic of, Australia
Bayer

Completed

Mirena Post-marketing Surveillance in Japan

Contraception

Japan
Bayer

Completed

Acceptability of Long-term Progestin-only Contraception in Europe

Contraception

Slovakia, France, United Kingdom, Ireland
Bayer

Completed

Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)

Menorrhagia

United States, Canada, Brazil, Mexico, Argentina
Bayer

Completed

Assessment of the Transfer of Using Levonorgestrel Intrauterine System (LNG IUS) as a Contraceptive to Using it as Part of Hormone Replacement Therapy (HRT).

Menopause

Belgium, Netherlands, Finland, United Kingdom

Search clinical trials for: Levonorgestrel IUS

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations